Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors
| Status: | Recruiting |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/28/2018 |
| Start Date: | April 26, 2017 |
| End Date: | November 30, 2019 |
| Contact: | Alexander Philipovskiy, MD, PhD |
| Email: | alexander.philipovskiy@ttuhsc.edu |
| Phone: | 9152155195 |
Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors - (AIs)
This is an observational trial designed to assess prospectively the adherence rate to AIs
among women with invasive breast cancer (stages I-III) currently receiving AI adjuvant
therapy after standard local and systemic therapy. We will study adherence by administrating
the 8-item Morisky Medication Adherence Scale (MMAS - 8).
among women with invasive breast cancer (stages I-III) currently receiving AI adjuvant
therapy after standard local and systemic therapy. We will study adherence by administrating
the 8-item Morisky Medication Adherence Scale (MMAS - 8).
- Women with breast cancer seen at the Texas Tech Physicians Breast Care Center will be
recruited during their routine follow-up visit with their medical oncologist.
- Post - menopausal women with histologically confirmed hormonal positive (ER and/or PR)
invasive breast cancer stages I - III with no evidence of metastatic disease (M0).
- Patients must be on one of AI (steroidal or non-steroidal).
- Patient must have completed local treatment (surgery /radiation) and recovered from all
side effects of chemotherapy and surgery.
- Patient must be able to complete a demographic and the MMAS - 8 questionnaires in
English or Spanish.
recruited during their routine follow-up visit with their medical oncologist.
- Post - menopausal women with histologically confirmed hormonal positive (ER and/or PR)
invasive breast cancer stages I - III with no evidence of metastatic disease (M0).
- Patients must be on one of AI (steroidal or non-steroidal).
- Patient must have completed local treatment (surgery /radiation) and recovered from all
side effects of chemotherapy and surgery.
- Patient must be able to complete a demographic and the MMAS - 8 questionnaires in
English or Spanish.
Inclusion Criteria:
- Post - menopausal women with histologically confirmed hormonal positive (ER and/or PR)
invasive breast cancer stages I - III with no evidence of metastatic disease (M0).
- Patient must have completed local treatment (surgery /radiation) and recovered from
all side effects of chemotherapy and surgery.
- Patient must be on one of AI (steroidal or non-steroidal).
- Patient must be able to complete a demographic and the MMAS - 8 questionnaires in
English or Spanish
Exclusion Criteria:
- < 18 years old
We found this trial at
1
site
El Paso, Texas 79912
Principal Investigator: Alexander Philipovskiy, MD, PhD
Phone: 915-215-5195
Click here to add this to my saved trials
